CM9241GRU

· Ache Laboratorios Farmaceuticos S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CM9241GRU, covering 2024-08-29 to 2024-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis [Phase 3]